Emergent Biosolutions (EBS) Stock Statistics & Valuation Metrics

Emergent Biosolutions has a market cap or net worth of $254.84M. The enterprise value is $983.86M.

Emergent Biosolutions has 54.34M shares outstanding. The number of shares has decreased by -2.65% in one year.

Emergent Biosolutions’s return on equity (ROE) is -0.39 and return on invested capital (ROIC) is -11.81%.

The current PE Ratio of Emergent Biosolutions is -2.66. Emergent Biosolutions’s PEG ratio is 0.04.

In the last 12 months, Emergent Biosolutions had revenue of $1.04B and earned -$190.60M in profits. Earnings per share was -$3.64.

In the last 12 months, operating cash flow was $58.70M and capital expenditures -$22.90M, giving a free cash flow of $35.80M billion.

Emergent Biosolutions pays an annual dividend of $1.85, resulting in a dividend yield of

Emergent Biosolutions upcoming earnings date is Apr 24, 2025, TBA.

Emergent Biosolutions as a current ratio of 3.69, with Debt / Equity ratio of 1.37

In the past 12 months, Emergent Biosolutions has paid $47.70M in taxes.

Emergent Biosolutions EV to EBITDA ratio is 29.02, with an EV/FCF ratio of 29.91.

Emergent Biosolutions has $99.50M in cash and marketable securities with $663.70M in debt, giving a net cash position of $564.20M billion.

Gross margin is 100.00%, with operating margin of -10.72%, and net profit margin of -18.80%.

The average price target for Emergent Biosolutions is $15.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy